Batch numbers and certificates of analysis can help you identify the exact medical cannabis product you have been supplied. They are useful for traceability, pharmacy queries and product-quality questions.
They are not a shortcut for choosing a product, changing treatment, judging whether a medicine is suitable for you, or deciding whether one batch is clinically better than another. Those questions belong with your prescriber or pharmacist.
This guide explains the patient-facing basics: what a batch number is, what a certificate of analysis may show, and how to ask sensible questions without turning lab paperwork into medical advice.
What a batch number is for
A batch number is a reference for a specific manufactured or supplied batch of a medicine. For unlicensed cannabis-based products for medicinal use, MHRA guidance says product labelling should include a batch number, along with other key information such as the product name, THC/CBD content where appropriate, expiry date, storage precautions and manufacturer details.
For patients, the batch number is most useful when something needs to be traced.
That might include:
- checking whether the product you received matches the prescription and pharmacy record;
- asking the pharmacy about an unusual appearance, smell, label or package issue;
- reporting a suspected quality problem;
- helping a clinic, pharmacy, supplier or regulator identify the relevant batch if a recall or investigation is needed.
You do not need to memorise the batch number. The practical step is to keep the medicine in its original labelled packaging and copy the batch number accurately when asking a question.
For label basics, read how to read a medical cannabis prescription label.
What a certificate of analysis may show
A certificate of analysis, often shortened to COA, is a batch-specific quality document. It is normally produced from testing carried out for the manufacturer, importer or supplier rather than as a patient treatment plan.
The details can vary by product, supplier and documentation route, but a COA may include:
- the product name or internal product reference;
- the batch or lot number;
- the testing date or release date;
- THC and CBD content, or a THC:CBD ratio where relevant;
- results for selected contaminants or quality tests;
- laboratory, manufacturer, importer or quality-release details.
Some cannabis documents may include extra product information, but do not assume every COA will look the same or include the same set of tests. If a clinic or pharmacy sends you a COA and you do not understand a line on it, ask them to explain what that result means in plain English.
What batch and COA documents can tell you
Batch and COA documents can help answer identification and quality-control questions.
They may help you confirm:
- which batch the product came from;
- whether the product document matches the label or packaging;
- what THC/CBD content is declared for that batch;
- whether the supplier has quality records for the batch;
- which batch to mention if you report a concern.
This matters because many cannabis-based products supplied privately in the UK are unlicensed medicines. GMC and CQC guidance both stress that unlicensed medicines carry a higher governance burden because they may not have been assessed through the normal UK marketing-authorisation process for safety, quality and efficacy.
That does not mean a prescribed product is automatically unsafe. It means the prescriber, pharmacy and supplier governance matters, and the paperwork should support traceability rather than marketing claims.
What they cannot tell you
A batch number or COA cannot tell you whether a product is right for your condition, whether it will help your symptoms, or whether you should ask for a different product.
It also cannot tell you:
- how much to use;
- when to use it;
- whether to change route or timing;
- whether driving law or impairment guidance applies to you;
- whether a side effect is caused by that product;
- whether one terpene or cannabinoid profile is better for you;
- whether a private prescription is legally valid in every situation.
The COA is product-quality information. It is not personalised medical advice.
If a result worries you, or if the document seems to conflict with your label or prescription, contact the pharmacy or clinic before changing anything.
How to ask your clinic or pharmacy about a COA
You can ask direct, practical questions without sounding difficult.
Useful questions include:
- Can you provide the certificate of analysis or batch-quality document for my current batch?
- Does this COA match the batch number on my packaging?
- What does this THC/CBD figure mean for identifying the product?
- Has this batch passed the supplier’s quality-release process?
- Is there anything on this document that changes how I should store, handle or query the product?
- Who should I contact if the product looks damaged, smells unusual, seems mislabelled or does not match the paperwork?
Keep the question tied to your prescription and your batch. Avoid using COAs as a shopping list or a way to rank products by strength.
If something does not match
Pause and ask before using the product if:
- the batch number on the COA does not match the packaging;
- the product name, form, strength or expiry date seems different from what you expected;
- the packaging is damaged or unsealed;
- the pharmacy label is unclear or appears to belong to a different product;
- the COA raises a contaminant, quality or release question you do not understand.
This is a normal medicines-safety check. Contact the dispensing pharmacy first if the issue is about the supplied product, label, packaging, batch or COA. Contact the clinic if the question is about suitability, side effects, treatment changes or whether the product still fits your care plan.
If you suspect a side effect, tell your medical team. NHS and NICE patient guidance both point patients toward the MHRA Yellow Card scheme for reporting suspected problems with medicines.
Keep the paperwork useful
A simple record is enough for most patients.
Keep:
- the original packaging with the pharmacy label attached;
- the batch number and expiry date;
- the COA or batch document if your clinic or pharmacy provides it;
- the date supplied;
- a note of who you contacted if you raised a concern.
Do not post COAs, labels or prescription photos publicly without thinking carefully about privacy. These documents can contain personal details, prescription information, supplier information and batch identifiers.
Read next
- How to read a medical cannabis prescription label
- How medical cannabis prescriptions are dispensed in the UK
- THC:CBD ratios explained
- Patient guide: getting started with medical cannabis in the UK
Sources
- NHS: Medical cannabis
- NHS England: Cannabis-based products for medicinal use
- NICE: Cannabis-based medicinal products guideline NG144
- MHRA: Supply unlicensed medicinal products, including CBPMs
- MHRA: The supply, manufacture, importation and distribution of unlicensed CBPMs
- GMC: Information for doctors on cannabis-based products for medicinal use
- CQC: Cannabis-based medicinal products: what CQC expects providers
